Doxorubicin (Dox)-induced cardiotoxicity (DIC) remains a serious health burden, especially
in developing countries. Unfortunately, the high cost of current preventative strategies has …

Abstract Angiopoietin-1 (Ang-1) and Vascular Endothelial Growth Factor (VEGF) are central
regulators of angiogenesis and are often inactivated in various cardiovascular diseases …

Palm fruit pollen extract (PFPE) is a natural source of bioactive polyphenols. The primary
aim of the study was to determine the antioxidant, antimicrobial, anticancer, enzyme …

Quince (Cydonia oblonga) leaves are traditionally reported to alleviate the risk of
cardiovascular disease. The study envisaged to explore the in vitro and in vivo …

Doxorubicin (DOXO) is an antineoplastic drug that is used extensively in managing multiple
cancer types. However, DOXO-induced cardiotoxicity is a limiting factor for its widespread …

The anti-tumor and anti-inflammatory effects of limonin have been established, here, we aim
to explore whether limonin can induce protective effects against doxorubicin (DOX) …

Doxorubicin (DOX), which is used as a chemotherapeutic agent in the treatment of tumors,
has limited use due to its toxicity in various organs and tissues. One of the organs where …

The clinical application of doxorubicin (Dox) is limited due to its cardiotoxicity, while the
pathogenesis remains to be fully understood. Recent studies have suggested that microRNA …

Background Adriamycin (ADR), a high-efficiency, broad-spectrum anthraquinone
chemotherapeutic agent, is currently used to treat various malignant tumors and can lead to …

Doxorubicin (DOX) is a powerful antitumor agent with a well-known cardiaotoxic side effects.
In the current study, the ameliorative combined impacts of montelukast (Mont) and Klotho …